N-pyrro Protonitazene HCL. 2000mg

Protonitazepyne (N-pyrrolidino protonitazene) is a benzimidazole derivative with a strong opioid side effect profile. It was definitively identified in early 2023. It is an analogue of etonitazene where the ethoxy group has been extended to propoxy, and the N,N-diethyl substitution has been cyclized into a pyrrolidine ring. While formal studies into its pharmacology haven’t been carried out, it is believed to be slightly less potent than the ethoxy+pyrrolidino analogue known as etonitazepyne but still a very potent opioid.